Masahiko Nakamura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Masahiko Nakamura has a total of 141 co-authors. Here are the top co-authors by number of shared publications:
Kanji Tsuchimoto
School of Pharmaceutical Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108- 8641, Japan.
23 shared publicationsTetsufumi Takahashi
School of Pharmaceutical Sciences, Kitasato University
21 shared publications- Hidenori Matsui
Kitasato University
17 shared publications Masaya Oda
10 shared publicationsToshifumi Hibi
Department of Internal Medicine Kitasato Institute Hospital Tokyo Japan
10 shared publicationsShinichi Takahashi
School of Medicine, Kyorin University, Mitaka, Japan
9 shared publications
Latest Publications
- 12 September 2018
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 24 (18) , 1961-1965
MALT Lymphoma, Stress Ulcer and Cholinergic Nerves from the Viewpoint of Bilateral and Unilateral Truncal Vagotomy and Substance P
Background: Vagal nerve plays an important role in the stomach function. The cholinergic nerves are the most abundantly distributed nerves in the gastric tissue. It has recently been reported that the vagal nerve is significantly related to both gastric cancer development and progression. However, its relation to the mesenchymal tumor, including MALT lymphoma, is not known. In this study, we investigated the effect of unilateral truncal vagotomy on gastric MALT lymphoma development by using Helicobacter heilmannii-infected mouse model as well as that of bilateral truncal vagotomy on stress-induced ulcer formation. Methods: In the first part of this study, the distribution of the cholinergic nerves in the rat gastric mucosa and the effect of bilateral truncal vagotomy, as well as various kinds of agents acting on autonomic nerves in rats, were investigated by the histochemical and macroscopic method. In the second part, we employed MALT lymphoma formation in C57BL/6NCrl mice that were infected with Helicobacter heilmannii. A total of 38 infected mice underwent unilateral vagotomy under microscopy. The mice were randomized into 4 groups from which samples were collected; 2, 3, 4 and 6 months after infection. Both the anterior and posterior sides of the stomachs were sampled from each mouse for pathological and immunohistochemical analyses. Results: The bilateral truncal vagotomy significantly suppressed the restraint-induced gastric ulcer formation in rats, while bethanechol, and 6-hydroxydopamine led to an increase of the gastric ulcer formation. In the unilateral truncal vagotomy study using MALT lymphoma, the thickness of the gastric mucosa was reduced in the vagotomized side compared to the non-vagotomized side. Furthermore, the gastric MALT lymphoma was more prominently found in the vagotomized anterior side of stomach compared with that in the non-vagotomized posterior side of stomach. Substance P-immunoreactive nerves markedly increased surrounding the MALT lymphoma and the neurokinin-1 receptor immunoreactive lymphocytes increased within the MALT lymphoma in the vagotomized side. In conclusion, vagotomy enhanced gastric MALT lymphoma development possibly through the substance P-neurokinin-1 receptor pathway.
- 12 September 2018
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 24 (18) , 1961-1965
MALT Lymphoma, Stress Ulcer and Cholinergic Nerves from the Viewpoint of Bilateral and Unilateral Truncal Vagotomy and Substance P
Background: Vagal nerve plays an important role in the stomach function. The cholinergic nerves are the most abundantly distributed nerves in the gastric tissue. It has recently been reported that the vagal nerve is significantly related to both gastric cancer development and progression. However, its relation to the mesenchymal tumor, including MALT lymphoma, is not known. In this study, we investigated the effect of unilateral truncal vagotomy on gastric MALT lymphoma development by using Helicobacter heilmannii-infected mouse model as well as that of bilateral truncal vagotomy on stress-induced ulcer formation. Methods: In the first part of this study, the distribution of the cholinergic nerves in the rat gastric mucosa and the effect of bilateral truncal vagotomy, as well as various kinds of agents acting on autonomic nerves in rats, were investigated by the histochemical and macroscopic method. In the second part, we employed MALT lymphoma formation in C57BL/6NCrl mice that were infected with Helicobacter heilmannii. A total of 38 infected mice underwent unilateral vagotomy under microscopy. The mice were randomized into 4 groups from which samples were collected; 2, 3, 4 and 6 months after infection. Both the anterior and posterior sides of the stomachs were sampled from each mouse for pathological and immunohistochemical analyses. Results: The bilateral truncal vagotomy significantly suppressed the restraint-induced gastric ulcer formation in rats, while bethanechol, and 6-hydroxydopamine led to an increase of the gastric ulcer formation. In the unilateral truncal vagotomy study using MALT lymphoma, the thickness of the gastric mucosa was reduced in the vagotomized side compared to the non-vagotomized side. Furthermore, the gastric MALT lymphoma was more prominently found in the vagotomized anterior side of stomach compared with that in the non-vagotomized posterior side of stomach. Substance P-immunoreactive nerves markedly increased surrounding the MALT lymphoma and the neurokinin-1 receptor immunoreactive lymphocytes increased within the MALT lymphoma in the vagotomized side. In conclusion, vagotomy enhanced gastric MALT lymphoma development possibly through the substance P-neurokinin-1 receptor pathway.
- 14 April 2016
- Published by Springer Nature
- p. 131-140
Gastric Non-Helicobacter pylori Helicobacter: Its Significance in Human Gastric Diseases
- 14 April 2016
- Published by Springer Nature
- p. 131-140
Gastric Non-Helicobacter pylori Helicobacter: Its Significance in Human Gastric Diseases
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S675
Mo1238 Helicobacter Heilmannii s.l. Infection Enhanced Parietal Cell Antibody As Well As Parietal Apoptosis: Relation to Type a Gastritis
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S675
Mo1238 Helicobacter Heilmannii s.l. Infection Enhanced Parietal Cell Antibody As Well As Parietal Apoptosis: Relation to Type a Gastritis
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S110
530 Possible Mechanism-of-Action of Naturally Occurring Isothiocyanates in Chemoprevention and Adjuvant Chemotherapy for Gastric Cancer
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S110
530 Possible Mechanism-of-Action of Naturally Occurring Isothiocyanates in Chemoprevention and Adjuvant Chemotherapy for Gastric Cancer
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S37
149 Angiogenesis and MALT Lymphoma in Stomach, Liver and Salivary Gland: Interaction With Vash2 and VEGF
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S37
149 Angiogenesis and MALT Lymphoma in Stomach, Liver and Salivary Gland: Interaction With Vash2 and VEGF
- Open Access
- 18 December 2014
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 29 (S4) , 70-76
Alteration of angiogenesis in Helicobacter heilmannii‐induced mucosa‐associated lymphoid tissue lymphoma: Interaction with c‐Met and hepatocyte growth factor
Background and Aim: The hepatocyte growth factor (HGF)/c‐Met pathway has attracted attention in the formation of malignant tumors, as HGF secreted from the microcirculatory components as well as residing macrophages has been suggested to act on the c‐Met receptors of cancer cells to decrease apoptosis and increase proliferation, invasion, and metastasis. The present study was undertaken to elucidate the interaction of the gastric, hepatic, and pulmonary mucosa‐associated lymphoid tissue (MALT) lymphoma induced by Helicobacter heilmannii infection with c‐Met and HGF.Methods: C57BL/6 female mice, infected with H. heilmannii for 3 months were used. The localization of the HGF, c‐Met, and HGF activator immunoreactivities was observed by the indirect immunohistochemical methods. In addition, the effect of c‐Met antibody and c‐Met inhibitor, PHA‐665752, was also investigated.Results: c‐Met immunoreactivity was found in the lymphocytes composing the MALT lymphoma, and HGF immunoreactivity was recognized mostly in the endothelial cells and macrophages in the MALT lymphoma. HGFA was localized on mesenchymal cells other than the lymphocytes. The administration of the antibody against c‐Met or the c‐Met inhibitor to the infected mice induced the significant suppression of hepatic and pulmonary MALT lymphoma, while the gastric MALT lymphoma showed only a tendency to decrease in size, while the active caspase 3 positive cells markedly decreased in the gastric, hepatic, and pulmonary MALT lymphoma after the treatment with the c‐Met antibody or the c‐Met antagonist.Conclusions: HGF and c‐Met pathway were suggested to contribute to the lymphomagenesis in the MALT lymphoma after H. heilmannii infection.
- 18 December 2014
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 29 (S4) , 70-76
Open AccessAlteration of angiogenesis in Helicobacter heilmannii‐induced mucosa‐associated lymphoid tissue lymphoma: Interaction with c‐Met and hepatocyte growth factor
Background and Aim: The hepatocyte growth factor (HGF)/c‐Met pathway has attracted attention in the formation of malignant tumors, as HGF secreted from the microcirculatory components as well as residing macrophages has been suggested to act on the c‐Met receptors of cancer cells to decrease apoptosis and increase proliferation, invasion, and metastasis. The present study was undertaken to elucidate the interaction of the gastric, hepatic, and pulmonary mucosa‐associated lymphoid tissue (MALT) lymphoma induced by Helicobacter heilmannii infection with c‐Met and HGF.Methods: C57BL/6 female mice, infected with H. heilmannii for 3 months were used. The localization of the HGF, c‐Met, and HGF activator immunoreactivities was observed by the indirect immunohistochemical methods. In addition, the effect of c‐Met antibody and c‐Met inhibitor, PHA‐665752, was also investigated.Results: c‐Met immunoreactivity was found in the lymphocytes composing the MALT lymphoma, and HGF immunoreactivity was recognized mostly in the endothelial cells and macrophages in the MALT lymphoma. HGFA was localized on mesenchymal cells other than the lymphocytes. The administration of the antibody against c‐Met or the c‐Met inhibitor to the infected mice induced the significant suppression of hepatic and pulmonary MALT lymphoma, while the gastric MALT lymphoma showed only a tendency to decrease in size, while the active caspase 3 positive cells markedly decreased in the gastric, hepatic, and pulmonary MALT lymphoma after the treatment with the c‐Met antibody or the c‐Met antagonist.Conclusions: HGF and c‐Met pathway were suggested to contribute to the lymphomagenesis in the MALT lymphoma after H. heilmannii infection.
- Open Access
- 1 February 2014
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 20 (7) , 1097-1103
New Pharmaceutical Treatment of Gastric MALT Lymphoma: Anti-angiogenesis Treatment using VEGF Receptor Antibodies and Celecoxib
In addition to eradication of Helicobacter pylori, chemotherapy with anticancer agents, and radiation therapy, the treatment with molecular target drugs including rituximab, a CD20 antagonist, is one of the promising new regimens. The mucosa-associated lymphoid tissue (MALT) lymphoma is histologically characterized by rich distribution of the microvascular network consisting of the immature capillaries, lymphatics and venules, and this microvascular network could be the target of the new pharmacotherapy in addition to the direct action on the accumulated B lymphocytes. We have established the animal model of the gastric MALT lymphoma by the Helicobacter heilmannii (H. heilmannii) peroral infection of C57BL/6 mice. The disease induced by this model is very similar to the human counterpart, because of the lymphoepithelial lesion characteristic of the human MALT lymphoma as well as the rich vascularization and localization of vascular endothelial growth factor (VEGF) and its receptors, Flt-1, Flk-1 and Flt-4. By administering VEGF receptor antibodies or celecoxib, one of the cyclooxygenase 2 inhibitors, we were able to induce a significant decrease in the size of the tumor and the apoptotic changes of the endothelial cells of the microvascular network. These antiangiogenic strategies were suggested to be candidates for the new pharmacological treatment of gastric MALT lymphoma, when other treatments are not effective.
- 1 February 2014
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 20 (7) , 1097-1103
Open AccessNew Pharmaceutical Treatment of Gastric MALT Lymphoma: Anti-angiogenesis Treatment using VEGF Receptor Antibodies and Celecoxib
In addition to eradication of Helicobacter pylori, chemotherapy with anticancer agents, and radiation therapy, the treatment with molecular target drugs including rituximab, a CD20 antagonist, is one of the promising new regimens. The mucosa-associated lymphoid tissue (MALT) lymphoma is histologically characterized by rich distribution of the microvascular network consisting of the immature capillaries, lymphatics and venules, and this microvascular network could be the target of the new pharmacotherapy in addition to the direct action on the accumulated B lymphocytes. We have established the animal model of the gastric MALT lymphoma by the Helicobacter heilmannii (H. heilmannii) peroral infection of C57BL/6 mice. The disease induced by this model is very similar to the human counterpart, because of the lymphoepithelial lesion characteristic of the human MALT lymphoma as well as the rich vascularization and localization of vascular endothelial growth factor (VEGF) and its receptors, Flt-1, Flk-1 and Flt-4. By administering VEGF receptor antibodies or celecoxib, one of the cyclooxygenase 2 inhibitors, we were able to induce a significant decrease in the size of the tumor and the apoptotic changes of the endothelial cells of the microvascular network. These antiangiogenic strategies were suggested to be candidates for the new pharmacological treatment of gastric MALT lymphoma, when other treatments are not effective.
- 1 January 2014
- Published by Japanese Society for Microcirculation in Microvascular Reviews and Communications
- Vol. 7 (1) , 35a
c-Met interaction with Angiogenesis and Stem Cell in Helicobacter heilmannii-induced gastric MALT lymphoma: Interaction with VASH-2
We established a low-grade MALT lymphoma model in C57BL/6 mouse infection of Helicobacter heilmannii obtained from cynomolgus monkey (Infect. Immun. 75 (3): 1214-1222, 2007). After long-term infection, we found the MALT lymphoma formation in the liver and lung in addition to gastric MALT lymphoma. Recently, c-MET, the tyrosine kinase receptor for hepatocyte growth factor (HGF) has attracted attention as one of the key players in survival and proliferation of B-cell malignancies. Thus, we have planned to clarify the difference of c-MET, HGF and HGF activator (HGFA) expression as well as VEGF and its receptors, Flt-1, Flk-1 and vasohibin-2 (VASH2) in gastric, hepatic and pulmonary lesions in the MALT lymphoma by immunohistochemistry. The effect of c-MET antibodies or inhibitor, PHA-665752 (10 mg/kg b.w.) on the formation of liver and lung lesion was also investigated. As a result, Nine months after the infection, small lymphocyte aggregates mostly composed of B cells were observed in the portal area of the liver and the peribronchial area of the lung as well as the gastric MALT lymphoma in approximately 50% of the infected mice. These lymphocytes were mostly centrocyte-like cells, and lymphoepithelial lesions characteristic of MALT lymphoma were also recognized. PCR and in situ hybridization analysis showed the existence of Helicobacter heilmannii not only in the fundic mucosa but in the lung and liver. Twelve and eighteen months after the infection, approximately 100% of infected mice had hepatic and pulmonary lesions. c-MET immunoreactivity was found in the lymphocytes composing the MALT lymphoma, and HGF immunoreactivity was recognized mostly in the endothelial cells and macrophages. HGFA was localized on mesenchymal cells other than the lymphocytes. The administration of antibodies against c-MET or a c-Met inhibitor to the infected mice induced the significant suppression of hepatic and pulmonary lesions as well as the gastric MALT lymphoma, while VASH2 immunoreactivity rather increased within the tumor. In conclusion, HGF and c-MET pathway were suggested to contribute to the lymphomagenesis and the VASH2 has a compensatory effect in the liver and lung after Helicobacter heilmannii infection.
- 1 January 2014
- Published by Japanese Society for Microcirculation in Microvascular Reviews and Communications
- Vol. 7 (1) , 35a
c-Met interaction with Angiogenesis and Stem Cell in Helicobacter heilmannii-induced gastric MALT lymphoma: Interaction with VASH-2
We established a low-grade MALT lymphoma model in C57BL/6 mouse infection of Helicobacter heilmannii obtained from cynomolgus monkey (Infect. Immun. 75 (3): 1214-1222, 2007). After long-term infection, we found the MALT lymphoma formation in the liver and lung in addition to gastric MALT lymphoma. Recently, c-MET, the tyrosine kinase receptor for hepatocyte growth factor (HGF) has attracted attention as one of the key players in survival and proliferation of B-cell malignancies. Thus, we have planned to clarify the difference of c-MET, HGF and HGF activator (HGFA) expression as well as VEGF and its receptors, Flt-1, Flk-1 and vasohibin-2 (VASH2) in gastric, hepatic and pulmonary lesions in the MALT lymphoma by immunohistochemistry. The effect of c-MET antibodies or inhibitor, PHA-665752 (10 mg/kg b.w.) on the formation of liver and lung lesion was also investigated. As a result, Nine months after the infection, small lymphocyte aggregates mostly composed of B cells were observed in the portal area of the liver and the peribronchial area of the lung as well as the gastric MALT lymphoma in approximately 50% of the infected mice. These lymphocytes were mostly centrocyte-like cells, and lymphoepithelial lesions characteristic of MALT lymphoma were also recognized. PCR and in situ hybridization analysis showed the existence of Helicobacter heilmannii not only in the fundic mucosa but in the lung and liver. Twelve and eighteen months after the infection, approximately 100% of infected mice had hepatic and pulmonary lesions. c-MET immunoreactivity was found in the lymphocytes composing the MALT lymphoma, and HGF immunoreactivity was recognized mostly in the endothelial cells and macrophages. HGFA was localized on mesenchymal cells other than the lymphocytes. The administration of antibodies against c-MET or a c-Met inhibitor to the infected mice induced the significant suppression of hepatic and pulmonary lesions as well as the gastric MALT lymphoma, while VASH2 immunoreactivity rather increased within the tumor. In conclusion, HGF and c-MET pathway were suggested to contribute to the lymphomagenesis and the VASH2 has a compensatory effect in the liver and lung after Helicobacter heilmannii infection.
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Su1665 Induced Expression of Cd86 in Gastric MALT Lymphoma by Helicobacter heilmannii Infection
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Su1665 Induced Expression of Cd86 in Gastric MALT Lymphoma by Helicobacter heilmannii Infection